about
Molecular targets of dietary polyphenols with anti-inflammatory propertiesResveratrol and cancer: focus on in vivo evidence.In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancerCyclooxygenases and lipoxygenases in cancer.Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPDResveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.Hopeahainol C monohydrate.Are certain lifestyle habits associated with lower Alzheimer's disease risk?Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits.Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol.Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivoAdvantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain.The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines.Progress in neuroprotective strategies for preventing epilepsy.Recent perspectives on the anticancer properties of aqueous extracts of Nigerian Vernonia amygdalina.Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells.Resveratrol-induced gene expression profiles in human prostate cancer cells.The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.
P2860
Q28192995-717BEBE2-7B10-4033-8FF7-48EA8857FD8CQ33578943-235516D7-FF1A-4205-B5ED-ECB08C9A0DE2Q34054238-7755A6A0-4781-43D7-B76B-1FDF733F9EECQ34224752-A2340903-9366-47A0-BB87-4568EE7D090CQ34542927-DCC74047-D8CA-425E-A09E-31FAE41C4C1AQ34880559-84861D2F-C167-4245-9623-2CF15E0956F9Q35060542-B33FF5CB-01E3-4DA9-B604-8DB20FDFBB98Q35515172-4ABB69F3-0C81-4A2E-B987-F09897EDDD71Q35758133-1E3B4114-F47C-4FC5-915C-A9E9475F1C0EQ35805767-E33400A2-1904-44A0-95F9-4A1E6D0759F6Q35872279-C1DF80F8-C672-4DE8-9074-FD6A72956C12Q35986909-C02551B2-0F1F-4758-BED2-0E3E014D202CQ36227449-00ED479F-631E-45BF-B139-CE65E7E98519Q36326423-A6A66359-FC4E-4708-B835-96BD366010BCQ36644183-7F9F7C40-5D31-466A-915B-BACDEB91C70CQ36670849-54600394-3D7D-4CCF-9B2F-BB4CA399F29DQ36739694-5E30C179-0DF7-44C0-A5A2-0794950D2A4FQ36926975-0D97519C-63F4-4B7F-8DDE-3A1C94C795E1Q37067366-03B0F03B-C11A-4AF4-9EE9-5C71ABD3AD3EQ37467489-D7AA178C-29A6-4176-A7A5-9895A4CD53BDQ37826817-427053CA-F6B7-40AF-9DD7-54BF9EC7D1A7Q38161333-9851EC41-C0B4-45C6-A417-EA404D5A6C52Q38663394-796EA48E-8DDE-45DD-9792-A081D81B2641Q42098076-D69D73FA-40E5-4493-8F1D-C0E447102337
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականին հրատարակուած գիտական յօդուած
@hyw
1999 թվականին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Cancer chemopreventive activity of resveratrol
@ast
Cancer chemopreventive activity of resveratrol
@en
Cancer chemopreventive activity of resveratrol
@nl
type
label
Cancer chemopreventive activity of resveratrol
@ast
Cancer chemopreventive activity of resveratrol
@en
Cancer chemopreventive activity of resveratrol
@nl
prefLabel
Cancer chemopreventive activity of resveratrol
@ast
Cancer chemopreventive activity of resveratrol
@en
Cancer chemopreventive activity of resveratrol
@nl
P1476
Cancer chemopreventive activity of resveratrol
@en
P2093
P407
P577
1999-01-01T00:00:00Z